Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001173 | 54.0478 | 2.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 55.0430 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 56.0620 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 56.0633 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 57.0578 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 57.0584 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 58.0421 | 14.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 58.0424 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 69.0571 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 70.0806 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 71.0733 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 71.0744 | 0.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 73.0895 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 73.0895 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 73.0896 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 75.0385 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 76.0026 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 78.0122 | 0.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 82.0787 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 83.0352 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 83.9528 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 85.0888 | 1.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 87.0318 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 89.0481 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 90.0443 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 92.0474 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 96.0677 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 98.0368 | 2.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 98.0372 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 98.0728 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 99.1046 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 99.1052 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 102.0153 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0448 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0993 | 21.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0995 | 21.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0995 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0995 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 103.0996 | 22.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 104.0614 | 16.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 106.0100 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 106.0622 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 110.1089 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 111.0690 | 2.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 113.0300 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 113.0841 | 4.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 114.1041 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 115.0980 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 115.1001 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 118.0782 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 119.0407 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 120.0434 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 124.9793 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 126.0316 | 3.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 129.0476 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 129.1520 | 4.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 130.0082 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 131.0682 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 131.9775 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 132.0229 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 132.0697 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 134.0724 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 135.0567 | 4.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 135.0647 | 4.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 135.0663 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 135.9926 | 0.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 136.0388 | 2.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 137.0835 | 2.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 138.0539 | 5.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 138.1043 | 6.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 143.0902 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 145.1100 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 146.0496 | 4.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 147.0863 | 0.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0151 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0156 | 20.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0157 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0168 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0183 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0523 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0524 | 18.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 148.0879 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 150.1041 | 10.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 151.0242 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 151.0263 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 152.0454 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 154.9664 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 156.0764 | 3.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 156.0764 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 157.1083 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 157.1085 | 2.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 157.1463 | 15.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 158.0844 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0338 | 2.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0354 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0354 | 10.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0355 | 8.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0356 | 7.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0356 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0357 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0357 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.0881 | 3.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.1253 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.1260 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 159.1263 | 0.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 160.0781 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 161.0325 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 161.0336 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 161.0363 | 2.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 162.0375 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 162.0678 | 20.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 162.1256 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 164.0453 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 166.0059 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 166.0297 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 166.0611 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 167.0562 | 2.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 169.0739 | 2.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 169.1093 | 7.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 170.0512 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 170.1410 | 10.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 171.0308 | 1.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 171.0422 | 5.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 171.0941 | 22.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 171.1617 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 172.0713 | 2.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 172.1461 | 14.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 173.0508 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 174.0259 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 174.0265 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 174.1405 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 175.0472 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 175.0634 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 175.0637 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 175.0641 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 175.0848 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 177.9389 | 0.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 178.0081 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 179.0054 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 179.1022 | 5.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 179.1285 | 15.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 180.0218 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 181.0716 | 1.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 181.0718 | 3.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 181.9422 | 2.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 181.9422 | 2.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 182.0906 | 4.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 183.0887 | 2.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 184.1077 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 185.1037 | 2.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 185.1762 | 18.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 185.2134 | 17.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 186.0461 | 1.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 186.0894 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 186.0994 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 187.0255 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 187.1214 | 7.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 188.0128 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 188.0605 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 188.0617 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 190.0967 | 10.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 190.0970 | 10.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 190.1568 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 190.1570 | 14.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 191.0484 | 2.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 191.0949 | 6.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 191.9542 | 0.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 192.0903 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 192.1508 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 193.0820 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 193.1432 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 194.0942 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 194.1130 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 194.1155 | 3.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 195.0533 | 10.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 195.0919 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 195.0933 | 0.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 196.1081 | 6.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 196.1204 | 4.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 196.1210 | 3.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.0289 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.0454 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.0801 | 1.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.0877 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.1400 | 1.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.1418 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 197.1776 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 198.0508 | 2.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 198.1616 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 198.1625 | 17.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 199.1572 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 199.1574 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 199.1574 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 199.1930 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 200.0666 | 2.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 200.1515 | 7.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 201.0845 | 5.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 201.1004 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 203.1152 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 203.1160 | 8.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 203.1504 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 203.9752 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 203.9763 | 19.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 204.0135 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 204.0782 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 205.0745 | 7.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | L-TRYPTOPHAN-15N2 [ISTD] (M+H)+ | 206.0845 | 3.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 206.0948 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 207.0558 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 207.0881 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 207.0895 | 6.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 208.0439 | 5.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 209.0072 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 209.0370 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 209.0378 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 209.0421 | 1.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 209.1077 | 1.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 210.0513 | 4.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 210.1357 | 7.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 210.1615 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 210.9932 | 2.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 211.0878 | 2.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 211.1117 | 6.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 211.2290 | 18.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 211.2291 | 19.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 212.1393 | 14.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 212.1393 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 213.2452 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 214.0213 | 1.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 214.0892 | 3.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 214.1183 | 7.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 215.0636 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 215.1120 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 215.1523 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 215.1885 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 216.0585 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 216.0972 | 3.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 216.9825 | 8.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 217.0094 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 217.1288 | 4.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 218.0186 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 219.0400 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 220.1174 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 220.1238 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 220.1762 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 221.0216 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 221.1388 | 12.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 221.1400 | 22.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 221.1740 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 221.1754 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 222.1233 | 10.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 222.1234 | 10.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 222.1345 | 7.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 223.1543 | 12.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 224.0263 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 224.1047 | 12.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.0092 | 4.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.0092 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.0984 | 8.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.1014 | 5.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.1341 | 7.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.1720 | 22.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 225.1733 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 226.0955 | 2.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 226.9896 | 19.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.0560 | 7.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.1883 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.1886 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.1889 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.2216 | 21.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 227.2607 | 17.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.0656 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.0902 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1059 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1124 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1128 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1336 | 11.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1338 | 9.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1444 | 4.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1477 | 2.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.1833 | 11.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 228.9644 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.0355 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.0373 | 0.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.1306 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.1671 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.1675 | 4.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.1678 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.1739 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.2404 | 17.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.2405 | 17.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 229.9933 | 1.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 230.0153 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 230.1276 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 230.1629 | 4.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 230.9627 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 231.0361 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 231.0561 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 231.1833 | 15.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 232.0712 | 10.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 232.1001 | 1.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 232.9763 | 1.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 233.1233 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 233.1258 | 1.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 234.0879 | 10.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 234.1612 | 19.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 234.1800 | 5.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 235.1554 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 236.0457 | 2.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 236.1485 | 9.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 237.1047 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 237.1345 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 237.1705 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.0986 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.1350 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.1372 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.1373 | 4.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.1540 | 17.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.1543 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.2048 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 238.2295 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 239.1159 | 6.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 239.1881 | 15.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 239.1881 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 239.2251 | 13.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 240.0247 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 240.0620 | 8.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 240.0968 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 240.1444 | 1.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 240.1502 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2031 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2038 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2039 | 16.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2044 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2044 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2769 | 11.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2770 | 18.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 241.2770 | 18.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.0466 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.0469 | 4.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.0828 | 18.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.1126 | 4.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.1981 | 13.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 242.2000 | 8.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 243.1473 | 4.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 243.1830 | 13.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 243.1837 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.0222 | 7.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.0400 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.0737 | 14.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.1075 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.1707 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 244.1743 | 0.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 245.0009 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 245.0031 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 245.1129 | 0.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 245.1199 | 18.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 245.1448 | 16.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 246.0870 | 2.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 246.1158 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 246.1621 | 11.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 246.1679 | 15.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 246.9978 | 8.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 247.1423 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 248.1469 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 248.1732 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 248.1733 | 18.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 248.9974 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.0824 | 5.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.0845 | 5.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.1174 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.1262 | 2.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.1708 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 249.1945 | 2.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.0651 | 4.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.0652 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.0698 | 2.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.0967 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.1530 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 250.1653 | 11.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.0968 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1206 | 19.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1220 | 5.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1244 | 5.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1358 | 1.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1499 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1510 | 14.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 251.1995 | 8.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.0761 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.1294 | 2.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.1418 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.1652 | 9.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.1656 | 15.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.1657 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 253.2037 | 18.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 254.2251 | 21.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.1142 | 5.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.1371 | 19.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.1757 | 16.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.1836 | 15.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.2194 | 20.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.2196 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.2561 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 255.9502 | 0.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 256.0281 | 4.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 256.0298 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 256.1106 | 16.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 256.1776 | 6.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 256.2153 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.0603 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.0735 | 4.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.1261 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.1991 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.1996 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.2352 | 17.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.2719 | 19.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 257.2723 | 19.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.0338 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.0843 | 5.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.1135 | 2.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.1262 | 17.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.1580 | 3.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 258.1810 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 259.1785 | 6.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.0792 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1031 | 14.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1032 | 14.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1210 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1277 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1475 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1716 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 260.1846 | 16.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | HEXANOYLCARNITINE (*) M+ | 260.1862 | 7.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 261.1178 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1205 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1221 | 6.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1227 | 2.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1593 | 2.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1698 | 16.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 261.1705 | 17.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.0676 | 4.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.0779 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.1129 | 10.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.1202 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.1395 | 0.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.1571 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 262.1648 | 12.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 263.1206 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 263.1504 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 263.1855 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 263.1865 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 263.2459 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.0416 | 2.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.1155 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.1448 | 9.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.1813 | 13.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.1819 | 8.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 264.9690 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.1308 | 4.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.1361 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.1658 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.1660 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.1988 | 17.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.2148 | 10.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 265.2153 | 9.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.0357 | 4.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.0358 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.1177 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.1187 | 3.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.1310 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.1362 | 1.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 266.1659 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 267.1454 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 267.1810 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 267.1815 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.0175 | 20.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.0213 | 19.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.1168 | 3.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.1317 | 15.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.1529 | 1.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 268.2012 | 21.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 269.9934 | 1.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 270.2296 | 12.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 270.9733 | 0.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 271.0789 | 6.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 271.1786 | 6.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 271.2148 | 18.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 271.2885 | 17.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.0519 | 2.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.0620 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.1040 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.1399 | 5.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.1595 | 12.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 272.2454 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.0307 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.0822 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.0822 | 1.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.1006 | 7.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.1941 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.1944 | 8.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.2665 | 17.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 273.2669 | 17.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 274.0044 | 4.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 274.1098 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 274.1332 | 6.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 275.1873 | 17.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 276.0532 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 276.0883 | 5.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 276.1338 | 14.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 276.1736 | 19.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 276.2075 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 277.1521 | 1.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 277.2017 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 277.2379 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 277.2401 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 277.2409 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 278.0323 | 10.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 278.1511 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 278.1520 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 278.1976 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1124 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1308 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1328 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1505 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1517 | 21.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1810 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1812 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.1822 | 15.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.2315 | 11.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.2388 | 11.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 279.2553 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 280.0876 | 16.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 280.1005 | 5.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 280.1072 | 9.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 280.1314 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 280.1621 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 281.1246 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 281.1312 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 281.1967 | 17.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 281.1974 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.0356 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.0620 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.1261 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.1265 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.1568 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.1712 | 5.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 282.2195 | 21.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 283.1466 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 283.1774 | 14.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 283.2144 | 18.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 283.2873 | 22.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 283.3237 | 21.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.0391 | 2.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.0597 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.0960 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.1211 | 6.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.1383 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.1415 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.1417 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.1713 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.2104 | 11.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.2392 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.2459 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 284.2460 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 285.0923 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 285.2660 | 17.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.0270 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.0312 | 19.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.1175 | 1.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.2256 | 11.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.2351 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.2615 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 286.9744 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.1486 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.1505 | 15.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.2461 | 20.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.2468 | 17.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.2813 | 18.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.2820 | 16.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 287.2823 | 19.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.0288 | 5.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.0425 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.1199 | 5.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.1239 | 5.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.1474 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.2411 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.2419 | 12.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 288.2774 | 14.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 289.0962 | 4.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 289.1074 | 7.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 289.2619 | 17.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.0375 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.0829 | 14.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.1135 | 15.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.1270 | 11.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.1843 | 3.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 290.1882 | 19.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 291.1098 | 2.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 292.0868 | 5.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 292.2001 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 292.2011 | 21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.0928 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.1289 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.1293 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.1482 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.1970 | 18.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.2076 | 10.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.2325 | 20.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 293.2705 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 294.0922 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 294.1051 | 18.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 294.1094 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 294.1238 | 4.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 294.1687 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 295.0581 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 295.1292 | 4.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 295.1767 | 15.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 295.2126 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 295.2404 | 17.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.0495 | 1.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.0495 | 1.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.1069 | 18.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.1417 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.1579 | 21.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.2087 | 14.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.2324 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.2471 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 296.2713 | 23.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.0746 | 2.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.1033 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.1203 | 2.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.1933 | 15.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.2283 | 15.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.2630 | 21.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 297.2644 | 19.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 298.0358 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 298.0748 | 4.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 298.0849 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 298.1051 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 298.1571 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 299.0924 | 4.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 299.0963 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 299.2778 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 299.3182 | 19.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 299.9779 | 0.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.0325 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1048 | 5.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1323 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1338 | 20.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1342 | 20.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1361 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.1710 | 19.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 300.2779 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.0619 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.1126 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.2383 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.2619 | 17.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.2681 | 11.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 301.2694 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.1400 | 4.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.1525 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.1561 | 2.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.1592 | 3.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.1666 | 10.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.2556 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 302.2560 | 14.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 303.0956 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 303.2932 | 18.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.0152 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.0926 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.1266 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.1266 | 1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.1554 | 5.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.1580 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.2418 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 304.2731 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 305.0731 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 305.1969 | 18.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 305.2682 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.0098 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.0245 | 2.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.0361 | 8.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.0874 | 19.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.0934 | 6.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.1055 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.1625 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 306.2277 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.0843 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.1841 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2098 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2099 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2145 | 16.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2473 | 20.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2613 | 14.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2871 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2874 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 307.2875 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1202 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1205 | 9.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1241 | 15.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1244 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1536 | 17.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.1967 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 308.2074 | 14.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.0890 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.1210 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.1924 | 13.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.2027 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.2275 | 20.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.2278 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 309.3036 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1196 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1215 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1221 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1788 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1812 | 21.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.1987 | 21.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.2554 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 310.2598 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.1017 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.1414 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.1879 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.2074 | 15.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.2927 | 16.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 311.3185 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.0043 | 1.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.0987 | 12.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.1048 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.1371 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.2265 | 21.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.2664 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.2668 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 312.2764 | 17.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 313.0770 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 313.0966 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.0213 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.0559 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.1163 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.1509 | 18.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.1667 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.1856 | 21.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.1928 | 5.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 314.2575 | 12.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.0957 | 2.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.1086 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.1091 | 11.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.1300 | 1.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.1301 | 1.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.2071 | 14.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.2176 | 20.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.2177 | 20.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.2215 | 19.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 315.2890 | 13.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1036 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1322 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1665 | 17.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1670 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1830 | 12.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.1998 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 316.2730 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.1075 | 1.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.1977 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.2331 | 21.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.2332 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.2597 | 17.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.2922 | 17.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.2929 | 16.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 317.3072 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.0319 | 1.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.1323 | 3.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.1885 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.1920 | 14.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.2861 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.2866 | 14.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 318.2873 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 319.0367 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 319.1756 | 15.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 319.1762 | 15.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.0618 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.1240 | 9.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.1242 | 10.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.1375 | 3.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.1782 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 320.2046 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.0545 | 10.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.0701 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.0701 | 1.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.0941 | 10.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.1390 | 5.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.1580 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.1692 | 4.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.2292 | 21.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.2636 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 321.3027 | 22.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.0870 | 5.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.0882 | 6.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.1046 | 8.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.1166 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.1549 | 3.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.1576 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.2194 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 322.2482 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.0939 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.2101 | 16.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.2170 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.2439 | 20.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.2806 | 21.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 323.3178 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.1359 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.1485 | 3.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.2629 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.2766 | 18.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.2769 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 324.2781 | 11.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 325.1367 | 2.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 325.2974 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 325.3709 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.0012 | 16.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.0713 | 19.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.1066 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.1079 | 0.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.1155 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.1404 | 6.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.1939 | 6.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.2427 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 326.3301 | 21.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 327.1019 | 11.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 327.1139 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 327.1325 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 327.2789 | 22.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 327.9981 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.0217 | 3.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.1241 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.1321 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.1322 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.1334 | 6.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.1475 | 19.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 328.2362 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.0658 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1102 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1143 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1397 | 10.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1442 | 4.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1587 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.1788 | 16.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.2216 | 16.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.2700 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 329.3047 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1023 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1060 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1238 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1238 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1331 | 3.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1334 | 8.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1472 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1829 | 19.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.1981 | 14.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.2784 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.2870 | 17.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 330.2879 | 17.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 331.1037 | 1.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 331.2858 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 331.3245 | 20.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 331.3250 | 19.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 332.1012 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 332.1613 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 332.1974 | 14.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 332.3041 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.0843 | 1.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.1075 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.2880 | 17.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.2979 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.3009 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.3037 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 333.9705 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.0993 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.0993 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.0999 | 7.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.1185 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.1621 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.1994 | 5.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 334.2180 | 23.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 335.0620 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 335.2153 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 335.3125 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 335.3189 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.0979 | 18.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.0987 | 7.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.0989 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.0989 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.1487 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.1508 | 21.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 336.1604 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.2028 | 2.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.2263 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.2592 | 21.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.2597 | 19.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.3343 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.3346 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 337.3350 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.0581 | 5.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.1301 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.1488 | 2.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.1512 | 21.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.2350 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.2694 | 10.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 338.2925 | 13.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 339.2541 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 339.2738 | 17.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.0200 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.1358 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.1692 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.1878 | 8.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.2582 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.2593 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 340.2974 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 341.0792 | 10.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 341.1560 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 341.1930 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 341.2312 | 6.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 341.2378 | 21.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.0172 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.0410 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.1371 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.1470 | 16.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.1475 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.2881 | 11.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.2895 | 19.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 342.3245 | 21.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.0511 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.1247 | 5.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.1264 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.2216 | 6.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.2505 | 21.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 343.3424 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.0823 | 8.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.1274 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.1397 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.1617 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.1794 | 21.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.2142 | 14.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 344.3039 | 18.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 345.0397 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 345.2644 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.0750 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.1426 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.1768 | 18.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.1784 | 14.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.2596 | 11.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 346.3194 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.0667 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.1427 | 7.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.2449 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.2495 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.2621 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.2790 | 21.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.3175 | 17.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.3176 | 16.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.9798 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 347.9830 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.0525 | 19.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.1146 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.1270 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.1330 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.1565 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 348.1765 | 6.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.0572 | 1.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.1137 | 2.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.1745 | 9.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.1755 | 4.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.1767 | 7.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.2102 | 12.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.2597 | 19.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.2609 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.3332 | 21.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.3344 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 349.9799 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.0495 | 0.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.0923 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.1285 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.1289 | 19.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.1664 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.2260 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 350.2446 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.1262 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.1408 | 4.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.1558 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.2029 | 16.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.2408 | 20.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.2415 | 20.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.2419 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.2439 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.3113 | 21.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.3118 | 20.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.3137 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 351.9772 | 16.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.0678 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.0985 | 7.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1098 | 10.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1106 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1141 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1253 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1442 | 20.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1445 | 20.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.1829 | 14.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.2244 | 21.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 352.2598 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.0693 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.0729 | 2.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.1259 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.1598 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.1893 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.3046 | 17.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 353.3221 | 22.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 354.0601 | 11.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 354.0762 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 354.1099 | 10.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 354.1105 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.0666 | 0.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.1724 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.2480 | 8.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.2853 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.2876 | 18.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.3408 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 355.9947 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.0811 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.0813 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.0816 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.0819 | 7.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.0824 | 8.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.2559 | 21.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.2605 | 21.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.3014 | 18.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 356.3041 | 11.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.1260 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.1268 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.1294 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.1616 | 19.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.1831 | 18.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.3016 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 357.3341 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 358.0811 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 358.0811 | 15.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 358.1717 | 3.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 358.1720 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 358.2293 | 17.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.0205 | 1.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.0249 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.0834 | 9.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.3073 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.3170 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 359.3545 | 21.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 360.1567 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 360.1614 | 22.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 360.1893 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 360.2747 | 13.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 360.3347 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 361.2963 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 361.2966 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 361.3186 | 16.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 361.3322 | 23.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.0306 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.1150 | 1.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.1735 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.1755 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.2201 | 19.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.2556 | 14.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.3020 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 362.3665 | 8.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1140 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1160 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1174 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1266 | 12.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1374 | 5.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1689 | 6.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.1690 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.2137 | 6.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 363.2197 | 21.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.1092 | 19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.1287 | 20.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.1925 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.2007 | 15.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.2482 | 8.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.2599 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.2697 | 19.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 364.3065 | 21.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.0330 | 0.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.0899 | 2.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.1076 | 1.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.1312 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.1636 | 18.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 365.1852 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1144 | 8.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1257 | 13.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1258 | 12.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1259 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1438 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1558 | 20.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1610 | 21.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1850 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.1877 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.3232 | 20.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 366.3233 | 20.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 367.4171 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.0752 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1245 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1246 | 6.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1247 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1258 | 13.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1260 | 12.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1262 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1395 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1639 | 14.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1662 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1766 | 21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1770 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.1996 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.2297 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.2899 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.3380 | 21.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 368.3388 | 20.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 369.1674 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 369.1921 | 1.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 369.2631 | 9.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 369.2637 | 10.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 369.3007 | 14.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.0027 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.0972 | 14.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.1398 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.1680 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.1754 | 14.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.1779 | 17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.2196 | 7.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.2323 | 15.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.2831 | 15.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 370.3081 | 23.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 371.0965 | 2.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 371.1666 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 371.2818 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.0467 | 15.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.0472 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.0550 | 12.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.1565 | 18.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.2060 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.3366 | 21.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 372.3703 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.0997 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.1074 | 10.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.1085 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.2656 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.2960 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.2961 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.2964 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.2966 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.3215 | 19.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 373.3328 | 23.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.0509 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.0907 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.0910 | 10.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.1089 | 1.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.1250 | 7.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.2056 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.2075 | 18.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.2444 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.3498 | 20.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 374.9876 | 1.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.0538 | 2.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.1074 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.1079 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.2809 | 23.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.2919 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3112 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3117 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3120 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3120 | 22.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3491 | 18.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.3639 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 375.9969 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 376.0393 | 11.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 376.0915 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 376.1099 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 376.1390 | 8.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.0952 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.1012 | 1.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.1097 | 4.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.1145 | 5.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.1543 | 8.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.1580 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.2275 | 8.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.2603 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.3214 | 22.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.3225 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.3481 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 377.9923 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 378.0628 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 378.0644 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 378.1643 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.0873 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.1580 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.1583 | 11.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.1652 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.2453 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.2712 | 22.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 379.2742 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.0945 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.0991 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.1051 | 9.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.1419 | 14.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.1777 | 5.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.2911 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.3384 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 380.3703 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 381.0507 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 381.0827 | 1.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 381.2095 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 381.2624 | 13.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 381.4334 | 21.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.1071 | 2.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.1097 | 8.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.1197 | 11.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.1687 | 0.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.1924 | 14.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.2361 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 382.3920 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.0451 | 1.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.1091 | 3.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.1092 | 2.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.2087 | 10.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.2690 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 383.3404 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.0501 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.0876 | 20.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.0990 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.1195 | 6.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.1495 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.1537 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.1734 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.2854 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 384.2854 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 385.2264 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 385.2585 | 9.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 385.3533 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1715 | 9.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1733 | 15.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1735 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1738 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1744 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1745 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 386.1883 | 18.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.0953 | 1.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.1460 | 0.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.2051 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.2186 | 15.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.2480 | 7.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.2602 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.2755 | 21.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.3121 | 22.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 387.3481 | 23.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.0189 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.1070 | 12.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.1074 | 12.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.1075 | 13.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.1252 | 3.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 388.1541 | 7.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.0755 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.1524 | 17.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.2592 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.2906 | 21.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.2907 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.2908 | 21.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.3237 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 389.3638 | 24.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.0205 | 15.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.0500 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.0591 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.1069 | 12.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.1079 | 12.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.1195 | 3.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.1582 | 19.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.1593 | 20.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.2023 | 16.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 390.3216 | 18.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.1397 | 6.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.1411 | 3.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.1485 | 0.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.1672 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.2450 | 10.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.2451 | 9.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.3038 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.3058 | 20.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.3072 | 21.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 391.3632 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 392.0720 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 392.1798 | 2.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 392.2038 | 7.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 392.2915 | 23.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.0718 | 1.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.0900 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.1399 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.1634 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.1658 | 1.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.1728 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.2567 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.2595 | 22.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.3033 | 19.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.3220 | 21.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 393.3228 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.1140 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.1209 | 9.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.1209 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.1596 | 5.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.2688 | 21.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.2696 | 21.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.3532 | 21.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 394.4486 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 395.1183 | 19.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 395.1457 | 9.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 395.2101 | 1.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 395.2762 | 15.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 395.3186 | 20.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.0631 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.0718 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.0734 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.0894 | 20.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1061 | 7.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1173 | 0.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1195 | 1.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1211 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1241 | 9.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1552 | 1.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.1990 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.2130 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.2275 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.2590 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.2845 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.2931 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.3202 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.3677 | 21.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.3697 | 21.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.3707 | 21.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 396.4064 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 397.2941 | 13.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 397.3666 | 18.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 397.9791 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.0675 | 18.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.1191 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.1217 | 8.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | S-ADENOSYLMETHIONINE (M+H)+ | 398.1394 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 398.1559 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.2445 | 21.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.3010 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.3824 | 21.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.3842 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 398.3863 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 399.0903 | 16.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 399.1601 | 19.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 399.2730 | 10.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 399.9755 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 400.1808 | 14.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 400.2793 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 400.3678 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 401.0859 | 2.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 401.0870 | 16.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 401.1184 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 401.2344 | 19.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 401.3488 | 21.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 402.0099 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 402.0866 | 9.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 402.1623 | 4.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 402.3086 | 16.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 402.7224 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.1171 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.1463 | 2.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.1999 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.3289 | 21.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.3333 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.3386 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 403.3431 | 23.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 404.0761 | 12.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 404.0815 | 12.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 404.1414 | 8.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 404.2546 | 21.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.0457 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.1106 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.1576 | 4.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.1656 | 5.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.2889 | 21.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.2921 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.3216 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.3229 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.3230 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.3267 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 405.3805 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.0321 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.0955 | 3.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.1542 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.1579 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.1814 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.1917 | 2.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.3094 | 23.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 406.3294 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1583 | 4.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1638 | 9.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1699 | 1.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1875 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1886 | 15.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1889 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.1911 | 11.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.2062 | 6.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.2373 | 9.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.3365 | 22.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 407.3584 | 21.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1227 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1384 | 5.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1553 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1558 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1559 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1569 | 15.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1677 | 18.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1689 | 17.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.1711 | 17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.2494 | 17.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.3198 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.3749 | 24.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 408.4072 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 409.1210 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 409.1312 | 10.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 409.1314 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 409.2531 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 409.3177 | 20.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.0899 | 12.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.1753 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.3373 | 23.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.3883 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.4199 | 23.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 410.4234 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 411.0852 | 2.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 411.2029 | 8.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 411.3349 | 21.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.0359 | 4.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.1204 | 9.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.1417 | 5.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.1835 | 22.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.2097 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.3174 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 412.3280 | 20.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 413.0726 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 413.0729 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 413.0735 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 413.1625 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 413.2937 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.0792 | 1.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.0882 | 7.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.0939 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.1175 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.1938 | 1.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2043 | 19.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2050 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2051 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2051 | 18.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2067 | 19.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2321 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2462 | 8.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.2976 | 22.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.3254 | 21.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 414.3813 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.0877 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.0887 | 4.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.0888 | 9.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.2110 | 19.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.2364 | 20.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 415.3630 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 416.0945 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 416.1029 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 416.1125 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 416.2689 | 18.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 416.3088 | 23.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.0656 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.0866 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.1785 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.1831 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.2150 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.2419 | 1.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.2675 | 21.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 417.3249 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 418.0521 | 12.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 418.0534 | 9.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 418.1028 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 418.2344 | 18.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 418.2702 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.0402 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.1702 | 1.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.2268 | 3.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.2753 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.3110 | 23.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 419.3957 | 22.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 420.0250 | 2.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 420.0491 | 12.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 420.0632 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 420.2259 | 21.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 420.2488 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 421.0617 | 1.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 421.1168 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 421.1646 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 421.1672 | 11.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 421.2856 | 23.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 422.1549 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 422.1842 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 422.3860 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.0970 | 1.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.1049 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.1408 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.1467 | 10.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.1479 | 9.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 423.3558 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1057 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1261 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1280 | 15.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1303 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1313 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1499 | 17.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1831 | 1.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1924 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.1981 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.2099 | 21.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.2149 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.2671 | 10.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.3164 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.3251 | 19.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.4035 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 424.4059 | 22.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.1156 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.1166 | 7.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.1991 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.1991 | 10.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.2907 | 20.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.3517 | 21.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 425.3518 | 22.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.0863 | 8.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.0876 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1230 | 18.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1308 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1331 | 12.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1354 | 10.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1470 | 10.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.1948 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.2946 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.3333 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.4180 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.4192 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 426.4192 | 22.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.0565 | 2.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.1383 | 4.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.1632 | 12.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.1973 | 8.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.2002 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.3045 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 427.3055 | 21.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.0966 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.0995 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.1134 | 4.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.1321 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.2101 | 16.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.3122 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.3125 | 22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 428.4292 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 429.0460 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 429.2908 | 18.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 429.3818 | 21.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.0319 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.0931 | 8.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.1016 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.1642 | 3.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.2863 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.3166 | 20.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.3179 | 20.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.3773 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 430.3781 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.1116 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.2292 | 1.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.2310 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.2312 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.2542 | 8.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.2728 | 8.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.3039 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 431.3752 | 23.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 432.0691 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 432.1101 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 432.1606 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 432.2054 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 432.2501 | 21.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.0212 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.0310 | 11.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.0858 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.0918 | 2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.0935 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.1182 | 2.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.1853 | 8.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.1981 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 433.4101 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 434.0256 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 434.1524 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 434.1887 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 434.1980 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 434.2821 | 21.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.0778 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.1085 | 2.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.1295 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.1322 | 3.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.1749 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.2137 | 6.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.2560 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.3373 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.3377 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.3745 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.3925 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 435.3929 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.0254 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1865 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1865 | 19.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1867 | 18.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1870 | 19.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1872 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.1876 | 20.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.2293 | 8.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.3527 | 23.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.3633 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.3666 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 436.4388 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 437.0548 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 437.1996 | 8.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 437.2027 | 9.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 437.2357 | 1.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.0258 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.0844 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.1221 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.1623 | 19.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.3818 | 21.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.4094 | 22.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.4196 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 438.4484 | 23.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 439.1421 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 439.1421 | 10.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 439.2131 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 439.2147 | 13.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 439.2148 | 12.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.0741 | 5.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.0936 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.0993 | 0.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.1417 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.2179 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.3670 | 22.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.3976 | 21.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.3976 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.4283 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.4307 | 23.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 440.4321 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.0434 | 1.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.0888 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.0947 | 7.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.1035 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.1303 | 7.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.1466 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.2075 | 21.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.2122 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.2643 | 19.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.2648 | 20.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 441.3087 | 16.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.1295 | 10.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.1538 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.1893 | 3.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.2623 | 22.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.2892 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.3279 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.3294 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.3324 | 19.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.4123 | 20.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.4133 | 21.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.4134 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 442.4147 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 443.1053 | 4.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 443.1208 | 8.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 443.1503 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 443.3978 | 23.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.1841 | 3.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.2183 | 22.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.2768 | 22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.2813 | 22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.3237 | 19.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.3239 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.3351 | 21.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.4265 | 21.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 444.4270 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 445.0999 | 12.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 445.2445 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 445.2475 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 445.3648 | 18.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 445.3742 | 21.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 446.0686 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 446.1132 | 12.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 446.1750 | 3.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 446.2485 | 9.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 446.3219 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.1601 | 10.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.1806 | 10.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.2021 | 3.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.2030 | 1.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.2347 | 9.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.3702 | 23.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 447.4267 | 23.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.1128 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.1432 | 18.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.2167 | 3.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.2791 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.2809 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.3407 | 17.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 448.3530 | 23.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.1627 | 11.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.1802 | 8.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.1822 | 1.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.1946 | 3.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.3373 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.3518 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.4079 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 449.4080 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 450.0770 | 13.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 450.0967 | 3.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 450.1499 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 450.1659 | 17.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 450.2019 | 19.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.0630 | 12.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.1113 | 2.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.1762 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.1779 | 14.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.1788 | 13.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.2729 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 451.3849 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1516 | 19.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1591 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1651 | 1.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1772 | 19.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1801 | 18.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1806 | 17.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1813 | 18.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.1834 | 14.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.2647 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.3272 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.3615 | 21.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.3945 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.4312 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 452.4319 | 23.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1037 | 11.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1113 | 5.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1416 | 0.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1573 | 10.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1573 | 11.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1929 | 9.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.1983 | 21.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.2307 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.2872 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 453.3109 | 22.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.0348 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.1010 | 12.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.1432 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.1638 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.1833 | 1.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.3042 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.3071 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.3294 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.4127 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 454.4215 | 22.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 455.1191 | 12.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 455.1194 | 11.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 455.2244 | 22.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 455.3635 | 21.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 456.1483 | 11.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 456.1574 | 10.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 456.3409 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 456.3903 | 21.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 456.4302 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 457.0656 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 457.1141 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 457.1171 | 12.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 457.1180 | 11.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 457.9355 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.1037 | 2.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.1215 | 7.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.1935 | 23.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.2734 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.3492 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.3549 | 22.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.4094 | 22.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 458.4100 | 22.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.1144 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2623 | 17.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2625 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2628 | 15.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2629 | 16.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2631 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2631 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 459.2753 | 18.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 460.2341 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 460.2471 | 6.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 461.1147 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 461.1251 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.0782 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.1030 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.1271 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.1886 | 1.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.1958 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.2963 | 22.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.3359 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 462.3426 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.1262 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.1425 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.1449 | 8.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.2794 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.2857 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.3389 | 11.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.3405 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.3670 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 463.4231 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.0857 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.1698 | 3.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.2132 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.3929 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.5057 | 7.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 464.8389 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.0428 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1294 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1381 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1444 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1584 | 18.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1937 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1937 | 14.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.1937 | 15.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.2104 | 8.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.2946 | 21.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.3104 | 21.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.3155 | 23.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 465.4013 | 22.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.0399 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1090 | 16.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1434 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1729 | 9.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1895 | 7.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1912 | 2.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.1990 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.2060 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.2371 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.2740 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.3522 | 11.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 466.3678 | 23.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.1363 | 9.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.1885 | 3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.2090 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.2702 | 20.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.3021 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.3027 | 21.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.3158 | 12.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 467.3824 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.0947 | 12.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1269 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1462 | 19.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1588 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1749 | 16.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1760 | 17.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1761 | 17.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.1772 | 17.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.2882 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.3533 | 23.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.4303 | 22.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 468.4656 | 23.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.1369 | 1.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.2516 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.2617 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.2821 | 20.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.3043 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.3774 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 469.4967 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.0721 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.1249 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.1250 | 18.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.1257 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.1259 | 18.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.1265 | 16.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.3600 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 470.4415 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 471.1445 | 11.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 471.2957 | 20.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 471.3332 | 21.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.1083 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.1415 | 11.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.2338 | 2.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.3387 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.3388 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 472.3698 | 23.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 473.0951 | 10.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 473.1304 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 473.1601 | 12.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 473.2771 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 473.2911 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.0594 | 11.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.1267 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.2265 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.2296 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.3184 | 10.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 474.3189 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 475.0279 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 475.2980 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 475.2996 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 475.3140 | 21.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 476.1340 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 476.1702 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 476.1974 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 476.3594 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.0608 | 5.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.0735 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.1008 | 11.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.1841 | 3.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.2287 | 18.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.2417 | 20.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.2444 | 10.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.3144 | 20.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 477.3795 | 23.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.0503 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.0725 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.1377 | 10.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.1950 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.1991 | 19.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.2345 | 20.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.3285 | 17.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.3294 | 18.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 478.3711 | 20.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.0492 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.0958 | 5.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.1764 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.2283 | 18.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.3042 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.4176 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 479.4192 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.1681 | 10.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.1683 | 10.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.1707 | 9.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2043 | 9.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2046 | 7.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2056 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2457 | 13.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2462 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.2560 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.3458 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 480.3913 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.0936 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.1502 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.3174 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.3543 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.4231 | 20.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 481.4238 | 20.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.0205 | 2.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.1141 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.1179 | 3.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.1292 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.1482 | 10.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.2203 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 482.3781 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 483.1114 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 483.1507 | 12.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 483.2197 | 4.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 484.1183 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 484.1319 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 484.2210 | 20.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 484.3757 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 484.4558 | 23.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.0748 | 8.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.0763 | 12.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.1128 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.1658 | 1.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.2717 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.3460 | 10.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.3471 | 11.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 485.4550 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.0954 | 17.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.0981 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.1568 | 11.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.1682 | 10.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.3184 | 21.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.3547 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.3797 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.4064 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 486.4403 | 23.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 487.2725 | 20.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 487.2938 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 487.2938 | 19.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 487.2940 | 19.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 487.2945 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 488.0919 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 488.2012 | 2.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 488.2369 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 488.3086 | 22.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.0521 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.1062 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.1105 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.1686 | 8.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.1692 | 8.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.1846 | 3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.2748 | 23.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.2846 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.2870 | 21.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 489.4170 | 23.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 490.1861 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 490.2282 | 1.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 490.2879 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 490.2938 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 490.3753 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.0459 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.1159 | 2.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.1216 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.1590 | 2.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.3978 | 23.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 491.4488 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 492.1416 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 492.2034 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 492.2332 | 17.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 492.3068 | 21.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 492.3529 | 22.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.0488 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.1347 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.1782 | 19.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.1783 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.2802 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.3141 | 21.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.3171 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.3874 | 21.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.4330 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 493.4339 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 494.0451 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 494.1449 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 494.1456 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 494.2024 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 494.2369 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.0707 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.1344 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.1687 | 9.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.1690 | 8.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.2020 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.3065 | 21.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.3337 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.4038 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.4159 | 21.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 495.4380 | 21.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 496.1397 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 496.1515 | 9.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 496.1533 | 10.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 496.3868 | 23.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 497.2199 | 12.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 498.1574 | 19.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 498.1576 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 498.1786 | 3.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 498.1791 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.1766 | 16.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.1786 | 15.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.1992 | 7.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.2240 | 2.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.2539 | 2.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.2701 | 21.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.2853 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.3869 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 499.4585 | 23.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 500.1780 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 500.3697 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 501.2060 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 501.2871 | 22.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 501.3048 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.1439 | 1.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.1520 | 11.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.1521 | 9.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.1588 | 2.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.3275 | 19.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.3279 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 502.3467 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 503.1847 | 8.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 503.2642 | 18.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 503.2996 | 22.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 504.0309 | 0.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 504.1736 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 504.2880 | 12.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.2035 | 3.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.2475 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.2516 | 21.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.2597 | 20.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.2859 | 21.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 505.4148 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.1297 | 1.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.1941 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.2172 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.3225 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.3411 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 506.3702 | 21.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 507.3329 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 507.3701 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 507.4361 | 23.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 507.4467 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.1802 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.1819 | 1.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.2119 | 7.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.2121 | 9.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.2705 | 17.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.3245 | 10.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 508.3496 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 509.1293 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 509.1630 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 509.3505 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 509.4280 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 509.4561 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 510.1513 | 2.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 510.2035 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 510.2526 | 22.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 510.2788 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 510.3893 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 511.1336 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 511.4074 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 511.4095 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 512.1715 | 1.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 512.2410 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 512.3077 | 4.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.1782 | 9.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.2502 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.3078 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.4029 | 22.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.4454 | 21.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 513.4822 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.1319 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.1538 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.1632 | 9.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.1632 | 10.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.3845 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 514.3853 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.1725 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.1726 | 12.15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.1990 | 7.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.2892 | 19.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.3031 | 21.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.4704 | 23.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 515.8925 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 516.1315 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 516.1689 | 12.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 516.1708 | 9.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 516.3641 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 516.3651 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 517.2299 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 517.2300 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 517.3081 | 22.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 517.3160 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.1177 | 9.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.1543 | 8.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.2983 | 19.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.3012 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.3220 | 17.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.3222 | 18.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.3223 | 18.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 518.3225 | 18.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 519.2867 | 23.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 519.3265 | 9.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 519.3335 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 519.4019 | 20.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 520.1378 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 520.1611 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 520.3038 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 520.3192 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.2772 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.3110 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.3490 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.3493 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.4635 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 521.5862 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 522.1589 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 522.4008 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 522.4032 | 20.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.0475 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.2698 | 22.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.3369 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.3654 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.3660 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.4450 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 523.4455 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 524.1352 | 2.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 524.1687 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 524.2806 | 9.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 524.3138 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 524.3479 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 525.2847 | 22.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 526.1199 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 526.1825 | 23.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 526.1976 | 21.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 526.4216 | 23.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.1732 | 14.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.1736 | 12.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.1952 | 7.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.1977 | 8.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.2669 | 21.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 527.3805 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 528.1384 | 1.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 528.1711 | 6.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 528.3625 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 528.4016 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 529.1077 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 529.2824 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 529.3043 | 19.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 529.3396 | 20.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 529.6090 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 530.2448 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 530.2887 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 530.3263 | 21.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 530.3434 | 22.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 530.3802 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.2468 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.2651 | 22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.3152 | 8.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.3157 | 8.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.3161 | 9.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 531.3308 | 22.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 532.1602 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 532.2000 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 532.2261 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 532.3396 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 532.3611 | 21.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 533.1580 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 533.2479 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 533.2800 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 533.2806 | 22.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 533.4725 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.1865 | 22.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.2242 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.2483 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.3133 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.3186 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 534.4125 | 15.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.1584 | 9.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.1595 | 8.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.1601 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.1890 | 4.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.3252 | 20.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 535.4651 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 536.1443 | 9.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 536.3325 | 21.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 537.2438 | 19.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 537.4607 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 537.4807 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 538.0123 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 538.2359 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 538.3302 | 16.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 539.1732 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 539.2118 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 539.2338 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 539.4393 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 540.2065 | 1.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 540.2134 | 21.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 540.2703 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 540.2859 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 540.4264 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.0634 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.3147 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.3159 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.3179 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.3179 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.3922 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 541.4796 | 21.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.1430 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.2181 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.2233 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.2256 | 0.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.2882 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.4415 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 542.6426 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.2393 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.2641 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.3313 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.3322 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.3324 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.3348 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.4128 | 21.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.4521 | 22.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 543.4600 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 544.1341 | 2.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 544.1405 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 544.2849 | 15.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 544.3970 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 544.4580 | 23.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.1821 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.1829 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.2503 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.2807 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.3465 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 545.3506 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 546.1559 | 2.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 546.1762 | 12.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 546.2970 | 15.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.0528 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.1807 | 7.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.1840 | 1.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.2006 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.2695 | 22.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 547.8744 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 548.0509 | 1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 548.2113 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 548.3355 | 1.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 548.3455 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 548.6052 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.0588 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.1314 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.1544 | 14.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.1550 | 12.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.2008 | 1.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.2406 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.3521 | 22.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.4609 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 549.6201 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 550.1227 | 1.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 550.2077 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 550.2453 | 1.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 550.3484 | 22.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 550.4158 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.0231 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.0540 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.1231 | 9.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.1348 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.1752 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.1855 | 1.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.2468 | 23.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.2527 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.3077 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 551.4760 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.2051 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.2525 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.2707 | 20.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.3050 | 21.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.3112 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 552.3829 | 23.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.1986 | 11.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2282 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2407 | 18.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2464 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2849 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2980 | 12.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.2989 | 8.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.4345 | 19.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.4346 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 553.4532 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 554.2184 | 7.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 554.2281 | 21.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 554.3827 | 21.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 554.4143 | 23.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 555.1409 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 555.2388 | 12.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 555.2988 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 555.4336 | 22.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 555.4353 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 556.3802 | 16.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 557.2631 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 557.2711 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 557.2798 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 557.4291 | 22.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 557.4765 | 21.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 558.3199 | 19.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 558.4135 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 558.4310 | 24.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 558.4731 | 23.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 559.1295 | 8.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 559.2961 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 559.2971 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 559.4035 | 23.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 560.1199 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 560.1835 | 5.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 560.3902 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 560.3909 | 22.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 561.1565 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 561.1925 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 561.3098 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 561.4939 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 562.1724 | 13.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 562.2103 | 2.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 562.2680 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 562.3087 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 562.4568 | 25.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 563.2111 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 563.2557 | 0.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 563.3005 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.1740 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.2042 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.2980 | 19.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.2980 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.3290 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 564.3629 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.1200 | 12.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.1200 | 14.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.2304 | 2.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.3160 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.4543 | 23.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.4848 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 565.4942 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 566.1890 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 567.3307 | 22.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 567.3317 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 567.3322 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 567.4711 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 567.4714 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 568.2063 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 568.2355 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 568.2441 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 568.3080 | 10.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 568.4131 | 22.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 569.1853 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 569.3485 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 569.3491 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 570.2343 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 570.3143 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.1137 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.1839 | 7.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.3277 | 21.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.3285 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.4005 | 22.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.4085 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 571.4254 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.1670 | 20.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.1981 | 9.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.1983 | 10.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.1988 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.2295 | 1.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 572.4138 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 573.2463 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 573.5070 | 21.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 574.1244 | 8.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 574.1261 | 9.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 574.1949 | 10.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 574.1970 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 575.0196 | 0.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 575.1220 | 4.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 575.2291 | 23.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 575.2721 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 575.3263 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 576.1223 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 576.1237 | 9.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 576.2464 | 2.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 576.3761 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 576.3889 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 577.1239 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 577.2688 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 577.2705 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 577.2829 | 1.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 577.3044 | 21.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 578.1149 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 578.2392 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 578.2872 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 578.3417 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 579.2639 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 579.2882 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 579.5043 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 580.2931 | 18.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 580.3587 | 21.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.1556 | 0.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2258 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2669 | 0.62 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2673 | 0.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2798 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2804 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.2973 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 581.4878 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 582.4121 | 17.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 583.1388 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 583.1781 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 583.2870 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 583.4541 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 584.3326 | 21.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 584.4665 | 23.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 584.7895 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 585.3014 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 585.3026 | 22.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 585.4221 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 585.5053 | 21.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 586.1768 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 586.5416 | 25.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 587.1932 | 1.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 587.2113 | 2.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 587.3770 | 20.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 587.4401 | 21.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 587.5112 | 21.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 588.1416 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 588.4225 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 588.4733 | 25.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 589.1425 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 589.3166 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 589.3169 | 22.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 589.3373 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 589.4094 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 590.2882 | 23.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 590.3931 | 23.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 590.4880 | 25.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 590.6065 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 590.8899 | 11.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 591.1665 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 591.3227 | 21.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 591.3313 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 591.5324 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 592.2878 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.0968 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.1636 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.1967 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.2005 | 1.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.2013 | 2.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 593.5483 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 594.1797 | 10.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 594.1806 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 594.2557 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 594.3196 | 21.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 594.3743 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 595.1320 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 595.3866 | 23.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 595.5024 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 595.5643 | 23.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 596.1048 | 8.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 596.1797 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 596.2141 | 11.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 596.2543 | 5.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 596.3236 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 597.1238 | 0.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 597.2602 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 597.2914 | 15 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 597.2932 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 597.4776 | 22.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 598.0942 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 598.2511 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 599.2528 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 599.2779 | 0.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 599.4527 | 22.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 599.4608 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 600.1003 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 600.2708 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 600.3288 | 5.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 600.5204 | 23.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.1521 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.1949 | 9.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.1955 | 7.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.2138 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.2724 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.4543 | 22.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 601.7312 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 602.0986 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 602.3791 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 602.4389 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 603.2833 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 603.3575 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 603.3781 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 603.4115 | 21.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 604.2423 | 3.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 604.4164 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 604.4170 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.2806 | 22.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.2806 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.3043 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.3245 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.3248 | 19.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.3359 | 21.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 605.4708 | 23.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 606.0937 | 10.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 606.0950 | 9.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 606.2339 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 606.2385 | 3.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 606.3169 | 21.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 607.1388 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 608.0953 | 9.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 608.1873 | 3.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 608.2776 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 608.3332 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 608.3831 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 609.1972 | 1.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 609.2749 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 609.5187 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 609.5646 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.1488 | 10.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.1717 | 3.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.2061 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.2232 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.2326 | 8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.2626 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 610.2804 | 18.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.2836 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.3183 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.3248 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.3369 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.4967 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.4979 | 22.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 611.6111 | 7.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.1477 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.1520 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | GLUTATHIONE OXIDIZED (M+H)+ | 612.1521 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | GLUTATHIONE OXIDIZED (M+H2)+2 | 612.1532 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 612.1785 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.2266 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.2718 | 20.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.3336 | 11.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 612.4766 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 613.2321 | 11.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 613.2341 | 10.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 613.2936 | 0.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 613.3336 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 614.1514 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 614.1515 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 614.2291 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 614.4889 | 25.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 614.4926 | 22.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 615.1552 | 11.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 615.4324 | 22.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.1614 | 9.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.2254 | 22.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.2399 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.4457 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.4521 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.5049 | 26.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 616.5085 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 617.1857 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 617.2424 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 617.3903 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.0824 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.0879 | 8.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.1284 | 0.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.2394 | 10.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.2407 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.2936 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.3048 | 23.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.3954 | 22.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.4325 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 618.5195 | 27.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 619.1740 | 1.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 619.2347 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 619.3514 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 620.2754 | 21.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 620.4060 | 21.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 620.5436 | 21.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 621.2962 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 621.5805 | 23.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.1805 | 5.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.1967 | 14.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.2082 | 1.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.2527 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.3134 | 21.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.3620 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 622.3680 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 623.1946 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 623.3026 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 623.5371 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 623.5956 | 23.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.1520 | 3.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.2446 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.2503 | 8.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.2975 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.3280 | 20.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.3280 | 21.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.3281 | 21.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.3719 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 624.6128 | 24.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 625.3221 | 17.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 626.1184 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 626.2246 | 3.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.2466 | 13.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.2472 | 11.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.2474 | 12.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.2832 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.2838 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 627.4849 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 628.1233 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 628.2209 | 3.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 628.4892 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 628.4988 | 25.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 629.4508 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 630.1634 | 0.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 630.1647 | 1.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 630.4718 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 631.1413 | 8.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 631.2095 | 2.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 631.4635 | 21.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 632.2077 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 632.2840 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 632.4486 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 633.1677 | 6.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 633.3043 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 634.1336 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 634.1345 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 634.2095 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 634.3674 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 636.1180 | 1.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 636.1378 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 636.2993 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 637.5998 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 637.6122 | 23.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.1421 | 9.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.1511 | 5.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.2221 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.2306 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.4009 | 22.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 638.4891 | 25.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 639.5286 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 640.2140 | 1.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 640.3222 | 21.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 640.3224 | 21.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 640.5047 | 25.66 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 640.5872 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.0988 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.1388 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.1848 | 9.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.2434 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.2989 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 641.5011 | 23.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2201 | 7.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2258 | 9.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2275 | 9.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2555 | 8.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2644 | 7.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.2727 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 642.5202 | 26.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 643.1807 | 10.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 643.2095 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 643.4851 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 644.2678 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 645.2054 | 11.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 645.2872 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 645.4220 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 645.4814 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 646.2060 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 646.2207 | 1.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 646.2538 | 20.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 646.4640 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 647.1411 | 1.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 647.1434 | 0.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 648.4412 | 22.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 648.4430 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 648.5098 | 26.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 648.6515 | 23.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 649.4344 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 649.4635 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 650.1013 | 1.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 650.1103 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 650.2137 | 18.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 650.2149 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 650.3179 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 651.0712 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 651.2212 | 8.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 651.2324 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 651.2813 | 22.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 652.2080 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 652.3575 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 652.3805 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 652.4142 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 653.3027 | 22.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 653.3234 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 653.5428 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 654.1172 | 5.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 654.1926 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 654.2062 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 655.5159 | 23.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 655.5231 | 22.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 655.5243 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 656.1164 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 656.3584 | 11.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 657.3024 | 22.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 657.4244 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 658.0605 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 658.2816 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 658.2891 | 19.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 658.3982 | 20.65 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 658.7813 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 659.3140 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 659.4406 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 659.4567 | 22.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 659.5494 | 23.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 660.0571 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 660.2612 | 21.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 660.4776 | 23.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 661.2301 | 13.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 661.2310 | 13.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 662.0562 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 662.4578 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 662.5446 | 26.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | NAD (M+NA)+ | 663.1085 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 663.1095 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | NAD (M+H)+ | 663.1097 | 1.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | NAD (M+2H)+2 | 663.1100 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001173 | 663.3387 | 21.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 663.4484 | 21.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 664.5050 | 25.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 665.2348 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 665.4287 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 665.6207 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 665.6805 | 26.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 666.1138 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 666.1882 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 666.2176 | 1.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 666.2842 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 666.3957 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 667.6125 | 22.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 668.1839 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 668.4111 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 669.2767 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 669.4019 | 21.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 669.5372 | 22.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 670.1578 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 670.1693 | 3.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 670.3038 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 670.5375 | 11.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 671.2516 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 672.1045 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 672.1748 | 3.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 672.2621 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 672.2625 | 22.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 672.3772 | 19.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 673.4750 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2054 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2489 | 6.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2582 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2658 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2744 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.2770 | 21.9 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 674.4837 | 22.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 675.4340 | 21.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 675.4350 | 21.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 675.4912 | 21.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 676.1709 | 1.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 676.4743 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 676.5376 | 22.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 677.2256 | 11.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 677.4725 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 678.2271 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 678.4167 | 22.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 678.5109 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 679.2430 | 5.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 679.3066 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 680.2370 | 1.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 680.6770 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 681.2430 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 681.3229 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 682.2112 | 10.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 682.2135 | 9.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 682.4268 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 682.5340 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 683.3148 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 683.5549 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 684.2556 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 684.4297 | 25.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 684.5281 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 685.3184 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 685.4473 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 686.2081 | 16.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 686.2085 | 14.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 686.2085 | 15.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 686.2089 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 686.3122 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 687.2106 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 687.4110 | 22.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 687.5114 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 688.2256 | 10.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 688.2829 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 689.3523 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 689.5076 | 22.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 689.5367 | 24.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.1370 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.1694 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.1798 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.1804 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.2713 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.3040 | 22.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.4375 | 19.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 690.4913 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 691.3413 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 692.1782 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 692.2122 | 2.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 692.3188 | 22.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 692.4675 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 692.4694 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 693.4587 | 22.99 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 693.4656 | 22.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 694.4095 | 22.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 695.2786 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 695.3342 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 695.6468 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 696.4068 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 696.4413 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 696.9876 | 6.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 697.2630 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 697.3204 | 6.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 697.5733 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 698.1765 | 10.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 698.1791 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 698.4637 | 22.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 698.5112 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 699.2782 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 699.5462 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 699.5497 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 700.1859 | 1.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 700.2240 | 17.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 700.5636 | 22.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 701.5242 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 702.2864 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 702.5421 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 703.2219 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 703.2662 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 703.4853 | 22.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 703.5242 | 22.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 704.1986 | 10.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 705.5606 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 706.1454 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 706.1455 | 15.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 706.1494 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 706.2327 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 706.6451 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 707.2993 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 708.1515 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 708.1826 | 2.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 708.1867 | 15.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 709.2974 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 709.3885 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 709.3965 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 709.4160 | 18.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 709.4188 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 710.1444 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 710.2044 | 9.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 710.4215 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 711.1729 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 711.3652 | 21.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 711.5830 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 712.4377 | 21.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 712.6172 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 713.2098 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 714.1515 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 714.2664 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 714.2966 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 714.3368 | 19.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 714.6305 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 715.2650 | 22.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 715.5399 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 716.0206 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 716.2420 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 716.4799 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 716.5318 | 23.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 717.5021 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 718.0156 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 718.2961 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 719.1719 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 719.5181 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 720.2517 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 720.4996 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 721.4908 | 22.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 722.1191 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 722.2033 | 12.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 722.2080 | 1.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 723.3687 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 723.4037 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 723.4053 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 723.5332 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 724.1195 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 724.1626 | 15.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 724.2324 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 724.6087 | 22.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 725.0814 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 725.3720 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 725.3873 | 21.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 726.2085 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 726.2321 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 726.2679 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 726.4532 | 22.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 726.6217 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 727.5801 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 728.1838 | 10.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 728.1983 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 728.6388 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 729.9939 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 730.1642 | 2.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 730.2351 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 730.3283 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 730.5837 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 731.5376 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 732.5867 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 732.6623 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 733.5338 | 22.24 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 734.1436 | 9.16 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 734.1440 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 734.2631 | 8.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 734.5160 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 734.5191 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 735.0444 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 735.2109 | 3.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 735.2171 | 10.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 735.4044 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 735.5362 | 25.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.1738 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.1780 | 9.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.1794 | 8.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.2776 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.3198 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 736.4957 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 737.3146 | 8.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 737.3879 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 737.4175 | 22.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 738.1722 | 12.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 738.1764 | 8.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 738.1816 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 738.5006 | 24.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 739.2577 | 25.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 739.3517 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.1516 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.1682 | 12.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.1690 | 1.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.2012 | 9.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.2282 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.4331 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.4643 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.5153 | 24.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 740.7372 | 8.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 741.2328 | 9.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 741.2550 | 25.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 741.4126 | 22.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 741.5669 | 25.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 741.5963 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 742.1654 | 10.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 742.1658 | 9.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 742.3365 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 742.6238 | 23.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 743.5472 | 24.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 743.5725 | 22.14 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 743.5770 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 744.1902 | 12.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 744.5055 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 744.6123 | 22.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 745.2436 | 10.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 746.1843 | 12.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 746.2024 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 747.2543 | 9.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 747.2942 | 22.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 747.5123 | 22.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 747.5440 | 22.41 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 748.2082 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 748.2820 | 22.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 749.1270 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 749.1980 | 3.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 749.5351 | 24.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 749.5670 | 23.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 750.2076 | 1.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 750.5107 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 751.5507 | 25.19 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 751.5651 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 752.1493 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 752.1572 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 752.1964 | 1.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 753.1411 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 753.3961 | 23.17 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 754.1948 | 9.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 754.2328 | 12.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 754.2376 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 754.3007 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 754.4484 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 755.6080 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.1704 | 9.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.1988 | 1.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.2475 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.2989 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.4626 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 756.6451 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 757.1736 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 757.4705 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 757.5895 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 757.5913 | 22.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 758.1001 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 758.1595 | 8.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 758.2592 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 758.6214 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 759.3676 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 759.5681 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 760.0952 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 760.1725 | 2.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 760.2930 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 760.4657 | 18.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 761.3274 | 0.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 761.5263 | 22.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 762.1405 | 0.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 762.1520 | 1.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 762.1884 | 9.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 763.1154 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 763.5441 | 21.91 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 763.5857 | 23.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 763.9742 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 764.0402 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 764.1863 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 764.3077 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 764.5259 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 765.2602 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 765.4148 | 20.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 765.5226 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 765.5636 | 25.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 767.2259 | 10.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 767.4967 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 767.5026 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 767.5459 | 24.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 769.2965 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 769.6307 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 769.9645 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 770.1976 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 770.4795 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 771.2494 | 1.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 771.2579 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 771.3029 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 771.6067 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 771.6381 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 772.1971 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 772.2258 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 772.5471 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 773.1940 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.1255 | 8.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.1492 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.2159 | 1.01 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.2299 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.3408 | 2.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 774.9527 | 11.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 775.5607 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 776.2137 | 12.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 776.6015 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 777.2276 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 777.5283 | 24.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 777.5594 | 22.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 778.5417 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 779.1923 | 5.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.1694 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.2399 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.4712 | 13.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.4785 | 19.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.4792 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 780.5217 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 782.1858 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 782.2377 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 783.1890 | 10.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 784.4582 | 22.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 784.4908 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 785.2170 | 10.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 785.6182 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 786.1686 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 786.2045 | 3.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 787.2069 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 787.5154 | 24.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 787.6031 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 788.1673 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 788.1997 | 3.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 788.6630 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 789.2245 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 789.4772 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 790.1281 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 790.1691 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 790.1806 | 2.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 790.4611 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 790.6447 | 22.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 791.5388 | 22.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 791.5747 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 792.1790 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 792.2120 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 792.5380 | 24.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 792.5488 | 22.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 792.5588 | 23.07 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.1796 | 12.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.2561 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.3266 | 15.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.3277 | 17.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.3278 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.3283 | 16.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 794.5370 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 795.3856 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 796.1834 | 1.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 796.2123 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 796.4512 | 19.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 796.4905 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 797.5252 | 25.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 798.1339 | 9.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 798.1950 | 12.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 798.2117 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 798.4741 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 799.2861 | 0.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 799.6334 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 800.4900 | 21.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 800.5690 | 22.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 801.6141 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 801.6160 | 22.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 802.2226 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 802.5366 | 23.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 802.7172 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 803.2335 | 10.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 804.2213 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 804.3102 | 7.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 805.5543 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 806.1515 | 2.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 807.2139 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 807.5700 | 21.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 808.1495 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 808.5523 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 808.5689 | 23.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 809.5394 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 810.2204 | 10.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 810.2931 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 810.2991 | 17.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 811.4591 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 811.5170 | 24.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 812.1859 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 812.2127 | 22.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 812.2189 | 10.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 812.2353 | 12.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 813.2338 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 813.2756 | 26.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 814.5051 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 815.1960 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 815.3941 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 815.5131 | 24.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 815.6317 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 816.6269 | 24.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 817.4761 | 15.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 818.4537 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 819.5257 | 22.64 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 819.5968 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 820.1965 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 820.4539 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 820.9063 | 22.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 821.2695 | 0.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 821.4185 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 821.5861 | 22.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 822.3585 | 17.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 822.3825 | 19.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 822.5687 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 824.5482 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 825.3918 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 826.1889 | 10.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 826.2598 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 827.4345 | 15.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 828.1821 | 1.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 828.2637 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 828.4836 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 828.5202 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 829.2598 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 829.5593 | 24.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 829.6454 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 830.4544 | 22.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 831.6292 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 831.7002 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 834.1720 | 0.67 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 835.4126 | 4.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 835.5638 | 22.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 835.5947 | 22.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 836.3887 | 19.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 836.5827 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 838.1327 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 838.5186 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 838.5617 | 22.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 840.2425 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 841.6419 | 22.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 842.1605 | 10.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 842.4996 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 843.2010 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 843.2537 | 0.76 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 843.5339 | 25.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 843.6602 | 23.08 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 844.2631 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 844.5148 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 844.5677 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 845.6422 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 845.6433 | 22.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 846.2603 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 846.4856 | 22.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 846.5370 | 22.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 848.4843 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 849.2038 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 849.5796 | 22.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.2508 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.3893 | 17.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.3904 | 19.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.3908 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.3915 | 19.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.3922 | 18.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 850.6038 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 851.5955 | 21.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 852.2472 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 852.4349 | 19.89 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 852.5787 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 853.5718 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 855.4681 | 24.2 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 856.0876 | 1.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 856.2971 | 16.33 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 856.4252 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 858.4304 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 858.5318 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 859.2573 | 12.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 859.6575 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 860.1817 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 860.2274 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 860.5176 | 24.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 860.6795 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 862.1800 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 863.3037 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 863.6138 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 864.5116 | 23.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 865.6122 | 22.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 866.2462 | 10.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 866.3662 | 19.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 866.3712 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 866.5948 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 868.5743 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 870.2438 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 872.2293 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 872.2368 | 12.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 872.4072 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 872.5098 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 872.5449 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 874.2284 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 875.6534 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 876.1999 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 876.4037 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 877.3493 | 5.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 878.4208 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 879.5688 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 879.5894 | 22.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 881.1646 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 881.2056 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 882.1715 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 882.2785 | 5.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 882.2798 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 882.3297 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 882.7829 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 883.4942 | 24.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 884.3327 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 886.2084 | 12.84 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 886.5141 | 22.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 886.5281 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 887.1917 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 888.2509 | 1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 888.3751 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 888.5429 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 888.5794 | 23.27 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 889.5065 | 24.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 889.6684 | 22.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 890.3773 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 890.5652 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 891.3560 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 891.3619 | 5.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 891.5601 | 22.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 891.8781 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 892.3748 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 893.6070 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 894.2128 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 894.3850 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 894.8787 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 895.6190 | 21.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 896.2026 | 0.73 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 896.6018 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 897.1848 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 897.5467 | 26.02 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 897.5976 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 898.3845 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 900.4016 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 900.4140 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 900.8532 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 901.2052 | 0.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 901.4632 | 24.74 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 902.3299 | 18.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 902.5583 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 903.4010 | 1.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 903.4066 | 0.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 904.2175 | 10.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 904.2185 | 9.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 908.6323 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 909.3051 | 9.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 909.6397 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 910.3528 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 910.6246 | 22.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 911.5205 | 25.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 911.5848 | 24.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 911.8869 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 912.3575 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 912.3614 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 912.4311 | 22.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 912.6005 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 912.8677 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 913.8609 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 914.3575 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 914.4292 | 22.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 916.2434 | 9.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 916.3663 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 916.5322 | 19.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 916.8673 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 917.2027 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 917.3890 | 1.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 917.5330 | 25.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 918.1460 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 919.6810 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 920.2348 | 5.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 922.2361 | 9.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 922.3845 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 922.8808 | 19.97 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 924.6268 | 23.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 925.3800 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 926.3309 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 926.6142 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 926.6166 | 22.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 928.3347 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 928.4289 | 22.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 928.4474 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 930.3392 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 930.5522 | 22.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 932.3379 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 933.3613 | 1.8 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 933.6929 | 22.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 934.3402 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 934.5910 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 935.4961 | 25.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 936.2623 | 1.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 936.3386 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 937.5278 | 25.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 937.6292 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 938.1829 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 938.3465 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 938.5890 | 23.21 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 939.3683 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 939.6423 | 21.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 940.4657 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 940.6279 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 941.5196 | 25.06 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 942.4605 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 943.5489 | 25.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 946.5824 | 22.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 947.7117 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 949.5640 | 24.09 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 950.5578 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 951.4724 | 24.75 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 953.6654 | 22.28 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 954.6454 | 22.92 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 955.3413 | 1.82 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 955.4994 | 25.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 956.6256 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 957.1538 | 12.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 957.3402 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 957.6023 | 23.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 958.5166 | 22.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 960.2285 | 8.83 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 960.4552 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 962.3026 | 10.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 963.5263 | 26.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 963.7040 | 22.44 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 964.5354 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 965.5231 | 24.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 966.6823 | 23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 967.2332 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 967.3091 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 968.5796 | 22.29 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 969.3151 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 970.6384 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 971.3081 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 973.3347 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 975.2826 | 9.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 976.1029 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 976.2119 | 8.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 977.7191 | 22.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 978.6196 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 979.5051 | 25.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 981.6556 | 22.37 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 982.6731 | 19.72 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 983.4979 | 24.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 984.2853 | 10.12 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 984.6547 | 22.79 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 986.5448 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 986.5763 | 22.86 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 987.2784 | 1.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 987.8139 | 22.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 988.5582 | 22.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 989.1885 | 12.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 990.3020 | 10.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 990.6034 | 22.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 991.7367 | 22.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 996.3560 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 996.8829 | 23.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1006.5353 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1008.4607 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1022.6431 | 22.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1024.2697 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1026.2653 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1028.6108 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1028.6230 | 22.31 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1030.6154 | 12.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1040.2441 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1044.2421 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1049.9517 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1050.5920 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1056.2144 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1056.6451 | 22.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1066.6302 | 22.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1072.2653 | 12.46 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1076.3726 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1078.6285 | 22.48 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1080.3820 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1084.3427 | 8.78 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1098.2826 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1100.2653 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1102.6443 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1110.6925 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1144.2437 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1150.5570 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1154.5704 | 19.94 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1168.6028 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1196.4565 | 16.34 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1197.3035 | 9.51 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1210.6685 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1213.8918 | 23.22 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1216.4670 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1218.4350 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1219.8470 | 22.61 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1220.3050 | 10.36 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1220.8323 | 23.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1230.6113 | 21.87 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1250.5471 | 4.25 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1271.9414 | 23.32 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1272.1837 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1280.5600 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1294.5750 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1306.1248 | 2.45 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1310.5518 | 22.53 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1327.5642 | 5.11 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1336.9128 | 23.49 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1346.5994 | 11.63 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1349.5413 | 5.13 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1354.5684 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1374.3416 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1378.3442 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1392.5143 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1398.2950 | 0.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1398.3011 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1404.3175 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1405.2345 | 23.26 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1406.5321 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1408.4857 | 7.05 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1418.3088 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1420.3254 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1422.3042 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1422.5130 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1426.6714 | 7.81 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1430.2823 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1440.2408 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1442.2217 | 12.55 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1454.4882 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1456.4902 | 7.04 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1466.6545 | 19.95 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1476.4824 | 8.4 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1480.4720 | 8.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1481.6210 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1484.6270 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1489.9456 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1490.6487 | 11.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1504.1084 | 23.68 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1511.0404 | 23.77 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1512.6315 | 11.35 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1520.4905 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1523.9385 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1529.9576 | 22.47 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1533.9637 | 22.1 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1605.6786 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1608.0111 | 22.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1620.1877 | 23.88 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1627.6617 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1643.6299 | 11.6 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1645.7076 | 12.18 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1662.4056 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1664.4060 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1664.9111 | 22.5 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1694.7667 | 18.3 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1716.7126 | 12.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1732.3940 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1734.7198 | 11.43 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1750.3801 | 12.58 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1752.3981 | 12.54 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1754.5382 | 9.52 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1754.6594 | 12.23 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1756.7021 | 11.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1768.3570 | 12.57 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1768.6552 | 8.38 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1770.3586 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1772.6632 | 11.42 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1778.3286 | 0.69 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1784.3455 | 12.59 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1790.6309 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1798.3654 | 12.56 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1806.5970 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1812.6158 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1818.7142 | 19.96 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1821.5690 | 8.39 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1838.7437 | 20.03 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1838.7491 | 19.93 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1914.7867 | 7.98 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1924.4733 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1980.4337 | 0.71 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | 1982.4476 | 0.7 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001173 | ISO-BUTYRYLCARNITINE (*) (M+H)+ | 2.85 | Minutes | ST000748 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |